HealthQuad, the growth venture arm of Quadria Group, has invested in LifeSigns, a Bengaluru-based startup focused on continuous AI-powered patient monitoring. While the financial details of the transaction remain undisclosed, the investment marks HealthQuad’s first institutional backing of the company.
Founded by Hari Subramaniam, LifeSigns has developed a predictive patient monitoring platform designed to address one of healthcare’s most persistent gaps: the inability of traditional periodic observation systems to detect rapidly changing patient risks in real time. The platform has already been deployed across more than 50 hospitals in India, particularly in tier 2 cities where healthcare infrastructure and staffing challenges remain significant.
The company’s US-FDA approved platform combines a medical-grade wearable device, a cloud-based monitoring dashboard, and a predictive AI engine capable of continuously tracking key patient vitals. These include ECG, heart rate, respiration, temperature, blood pressure, and oxygen saturation. By integrating real-time patient data into an AI-led analytics system, the platform can identify early signs of patient deterioration up to 26 hours in advance and flag critical risks within a four-hour window.
The technology is designed to function across the full healthcare continuum, including ambulances, emergency rooms, intensive care units, general wards, and home-care environments. In addition, a central monitoring command centre enables hospital staff to remotely oversee multiple patients simultaneously, helping healthcare providers address the ongoing shortage of nursing and clinical personnel, particularly in non-metro regions.
According to the company, the platform has generated more than 87,000 life-saving alerts to date, reduced code blue incidents by nearly 90%, and lowered ICU readmissions by close to 78%. These outcomes reflect the growing role of AI, predictive analytics, and digital transformation in reshaping healthcare delivery and improving patient safety.
LifeSigns also operates on a frugal, occupancy-based pricing model, allowing hospitals to pay based on patient volumes rather than fixed subscription costs. This approach is aimed at making advanced patient monitoring technology more accessible to smaller hospitals and healthcare facilities across emerging markets and underserved regions.
The investment comes amid a broader surge in demand for AI-enabled healthcare infrastructure, as providers increasingly prioritise data-driven decision-making, operational scalability, and preventive care models. With predictive monitoring gaining traction globally, healthtech startups leveraging AI and cloud-based systems are expected to play a larger role in the future of connected healthcare.
“No patient should deteriorate silently because systems are not designed to continuously monitor them. That belief built LifeSigns. Our platform has demonstrated both clinical impact and scalability in India. With HealthQuad and Quadria, we now have the strategic depth to take this model global and make predictive care the standard,” said Hari Subramaniam, Founder and CEO of LifeSigns.
Rahul Agarwal, Partner at HealthQuad, said, “Healthcare today is built on periodic observation while risk is real time. The future lies in continuous monitoring led predictive intelligence. LifeSigns is building that layer to detect deterioration early and enable timely intervention which can significantly improve outcomes and reduce healthcare costs at scale. This is a globally relevant model and where the next wave of healthcare will be built. With access to Quadria’s ecosystem, we are well positioned to help Hari and LifeSigns team to scale across global markets.”
